DALLAS, TX — Long-term ischemic and bleeding risks climb with advancing age in elderly patients medically managed for acute coronary syndromes (ACS), as might be expected, but adding low-dose ...
Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
Among secondary-prevention patients who are event free for 6 to 18 months after PCI, clopidogrel seems to be superior to aspirin monotherapy over the next 2 years regardless of the patient’s baseline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback